Marion van Mackelenbergh

11PUBLICATIONS
110CO-AUTHORS
BiofabricationPredictive and prognostic markersHaematological tumoursCancer geneticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 20, 2025
Light-based multi-material bioprinting of vascularised adipose tissue for breast fatty tissue engineering.

Nina Hedemann, Alexander Thomas, Nils Tribian

|Jan 30, 2025
Surrogate End Points for Overall Survival in Neoadjuvant Randomized Clinical Trials for Early Breast Cancer.

Fabio Conforti, Valentina Nekljudova, Isabella Sala

|Jan 09, 2025
RAD51 Testing in Patients with Early HER2-Negative Breast Cancer and Homologous Recombination Deficiency: A Post Hoc Analysis of the GeparOLA Trial.

Guillermo Villacampa, Alba Llop-Guevara, Natalie Filmann

|Nov 22, 2024
Calculating Future 10-Year Breast Cancer Risks in Risk-Adapted Surveillance: A Method Comparison and Application in Clinical Practice.

Silke Zachariae, Anne S Quante, Marion Kiechle

|Jun 05, 2024
An Analysis of PIK3CA Hotspot Mutations and Response to Neoadjuvant Therapy in Patients with Breast Cancer from Four Prospective Clinical Trials.

Paul Jank, Thomas Karn, Marion van Mackelenbergh

|Jul 11, 2023
Caveolin Gene Expression Predicts Clinical Outcomes for Early-Stage HER2-Negative Breast Cancer Treated with Paclitaxel-Based Chemotherapy in the GeparSepto Trial.

Terence M Williams, Andreas Schneeweiss, Christian Jackisch

Pageof 2

Frequent Collaborators

8 joint publications

Sibylle Loibl

8 joint publications

Carsten Denkert

7 joint publications

Valentina Nekljudova

6 joint publications

Peter Fasching